MAP2K6 and glioblastoma: On the contrary, in GBM cells the transcriptional downregulation of TRIM9s decreases its protein levels, generating a consequent increase in MKK6 proteasomal degradation, reduction of p38 activation, degradation of the remaining TRIM9s molecules and ultimately tumor progression.